Stock v. Gray et al. [Missouri Board of Pharmacy]
HLLI filed suit on behalf of a pharmacist who challenges a new Missouri law that would prevent pharmacists in the state from communicating with physicians or patients to dispute the effectiveness of ivermectin or hydroxychloroquine for human use as a COVID-19 treatment.